SIGNATOPE GmbH

SIGNATOPE GmbH was founded in August 2016 in Reutlingen by Thomas Joos, Hannes Planatscher, Oliver Pötz and Octavian Schatz, together with the NMI Natural and Medical Sciences Institute at the University of Tübingen. SIGNATOPE devel-ops innovative protein assays that are capable of detecting and quantifying biomarkers for organ damage and drug interactions in blood, urine and tissue. In addition, SIGNATOPE offers analytical services for clients in the pharmaceutical and chemical industries. The company’s CEO is biochemist Dr. Oliver Pötz.